Health
Centre approves Corbevax as precaution dose
New Delhi, Aug 10 : The Centre on Wednesday approved Biological E's Corbevax as a heterologous precaution dose for adults above 18 years for restricted use with two doses of either Covishield or Covaxin, said a source.
According to the source, the Corbevax vaccine will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines.
Meanwhile, India on Wednesday reported 16,047 new Covid-19 cases in the last 24 hours.
In the same period, there were 54 additional deaths, taking the nationwide death toll to 5,26,826.
4 hours ago
Protester dead after setting himself on fire across from Trump trial in New York
4 hours ago
Indian student's death in US possibly linked to Blue Whale suicide game
17 hours ago
Cong Corporator slams CM Siddaramaiah, says gang behind daughter’s murder
18 hours ago
188 Guggenheim Fellowship Include Four Indian Americans
18 hours ago
1 in 10 Asian Americans Face Poverty, Defying Stereotypical Success Assumptions
18 hours ago
The United States will not send election monitors to India.
18 hours ago
At the GOPIO 2024 conference, the role of India's diaspora will be highlighted.
18 hours ago
Maulik Pancholy Barred by Pennsylvania School District
18 hours ago
IOC Team in Karnataka to boost Congress
18 hours ago
The New Jersey India Commission has appointed Rajpal Bath as its executive director.
18 hours ago
Indian insurance industry in FY24: Non-life grew by 12.8 pc, life at 2 pc
20 hours ago
Tamil Nadu records 40.05 pc voting till 1 pm
20 hours ago
Maha: 5 Vidarbha constituencies records 32.36 pc polling till 1 pm